通过调解BCL2诱导的SOX9表达,IRF4有助于IGH::BCL2阳性扩散大B细胞淋巴瘤中的化学抵抗
Yirong Zhang1, Zizhen Xu2, Ruixin Sun1,2
1Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.
Clinical and translational medicine
|May 13, 2025
概括
向IRF4可以克服BCL2过度表达的扩散大B细胞淋巴瘤 (DLBCL) 中的化学抵抗. 这项研究揭示了IRF4驱动SOX9表达,这是DLBCL耐药性的关键因素.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 的复发率很高.
- SOX9是BCL2-过度表达DLBCL的预后生物标志物,对淋巴发育至关重要.
- 在DLBCL中调节SOX9表达的机制尚未完全理解.
研究的目的:
- 研究DLBCL中异常SOX9表达的分子机制.
- 确定SOX9在DLBCL化学抵抗中的作用.
- 在DLBCL中评估IRF4作为治疗点.
主要方法:
- 细胞活力,细胞亡和细胞周期测试.
- 蛋白质相互作用和无处不在的研究.
- ChIP-seq,ChIP和双露西法酶记者测定.
- 在体外和体内对IRF4抑制的评估.
主要成果:
- 在过度表达DLBCL的BCL2中,SOX9赋予了化学阻力.
- IRF4被确定为BCL2诱导的SOX9表达的关键调节者.
- BCL2增强了IRF4的核活性,促进了SOX9的表达和耐药性.
- 在DLBCL模型中,IRF4抑制降低了淋巴发育和化学抵抗.
结论:
- 在DLBCL中,IRF4对于BCL2诱导的SOX9上调是必不可少的.
- 针对IRF4为复发性/耐药性DLBCL提供了一个有希望的治疗策略.
- 抑制IRF4可以克服BCL2-过度表达DLBCL中的化学抵抗.
关键词:
在BCL2中,BCL2是IGH::BCL2-阳性 DLBCL:BCL2阳性的 DLBCL在 IRF4 基础上,IRF4 是一个 IRF4 项目.这就是SOX9的SOX9.化学电阻是一种化学电阻.更多相关视频
相关概念视频
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
The Intrinsic Apoptotic Pathway
5.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.7K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K


